厚颜
发表于 2025-3-30 08:58:01
Small Molecules Targeting the miRNA-Binding Domain of Argonaute 2: From Computer-Aided Molecular Des (miRNA) mimicking compounds able to bind the miRNA-binding domain of Argonaute 2 protein (AGO2) to inhibit miRNA loading and its functional activity were described. Computer-aided molecular design techniques and RNA immunoprecipitation represent suitable approaches to identify and experimentally de
山羊
发表于 2025-3-30 13:03:50
http://reply.papertrans.cn/29/2832/283130/283130_52.png
治愈
发表于 2025-3-30 18:25:22
http://reply.papertrans.cn/29/2832/283130/283130_53.png
Condescending
发表于 2025-3-30 23:38:09
Drug Target miRNA978-1-4939-6563-2Series ISSN 1064-3745 Series E-ISSN 1940-6029
circumvent
发表于 2025-3-31 04:22:04
Jan Feindt,Claudia Janßen,Stefan Sölbrandtle oncogenic pathways and, therefore, provide a strong rationale for developing therapeutic miRNA mimics in combination with other therapeutic cancer agents to augment drug sensitivity. Here, we describe the experimental approach for evaluating miRNA and drug combinations using the “fixed ratio” method in cultured non-small cell lung cancer cells.
CHOIR
发表于 2025-3-31 08:45:36
http://reply.papertrans.cn/29/2832/283130/283130_56.png
学术讨论会
发表于 2025-3-31 12:18:04
http://reply.papertrans.cn/29/2832/283130/283130_57.png
RAFF
发表于 2025-3-31 16:10:49
Evaluating Synergistic Effects of miR-34a Mimics in Combination with Other Therapeutic Agents in Culle oncogenic pathways and, therefore, provide a strong rationale for developing therapeutic miRNA mimics in combination with other therapeutic cancer agents to augment drug sensitivity. Here, we describe the experimental approach for evaluating miRNA and drug combinations using the “fixed ratio” method in cultured non-small cell lung cancer cells.